Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Carpal tunnel syndrome is a common nerve compression disorder in the upper limbs causing pain, numbness, and tingling in the fingers, often worse at night. The FINCROSS trial is a randomized crossover study that evaluates the effects of night-time and full-time wrist splinting compared to no treatment. It also aims to identify which patients might benefit most from splinting and whether a positive response reduces the need for surgery. Participants will undergo three treatment periods in random order wearing a wrist splint at night for six weeks, wearing the splint day and night for six weeks, and a six-week period without treatment. Each treatment phase is separated by a three-week washout period, making the full sequence 24 weeks long. Participants will also perform self-administered wrist stretching exercises throughout the study and avoid other medical interventions. During the study, participants will be assessed using symptom scales such as the 6-item CTS Symptoms Scale and the Boston Carpal Tunnel Questionnaire at baseline, mid-treatment, end of each treatment, and one year after randomization. Researchers will monitor symptom changes, quality of life, adverse effects, need for surgery, and use of escape treatments. Follow-up continues up to one year after starting the study.
Actively Recruiting
The trial investigates two different ways to stop high flow nasal cannula treatment in infants with acute bronchiolitis, a common cause of hospitalization in young children. Researchers want to find out if stopping the therapy immediately is safe and helps to reduce hospital stay, compared to slowly reducing the flow rate. Acute bronchiolitis mainly affects infants under one year and currently has no effective medication treatment in Finland. Participants will receive one of two approaches either the high flow nasal cannula is stopped immediately or the flow rate is gradually decreased until it ends. Typical high flow rates used are about 2 liters per kilogram per minute. The study compares these two strategies to see which method is more effective and safe for infants. During the study, infants will be monitored for treatment success, hospital stay length, and any readmissions within a week after discharge. Oxygen levels and suitability for ending therapy will be assessed by doctors. Researchers will measure hospitalization time starting from when they are assigned to a treatment method. The trial lasts for one week after randomization, with safety and treatment failure closely observed.